UPDATE 1-FDA approves first generic version of Teva MS drug Copaxone

April 16 (Reuters) - The U.S. Food and Drug Administration approved on Thursday the first generic version of Teva Pharmaceuticals Industries Ltd's top-selling multiple sclerosis drug, Copaxone.